Wall Street ends lower as tariffs sour sentiment
Trump late on Thursday ramped up his tariff assault on Canada, saying the US would impose a 35 per cent tariff on imports next month and planned to impose blanket tariffs of 15 per cent or 20 per cent on most other trading partners.
The S&P 500 eased from a record high the day before, with caution prevailing after Trump on Thursday imposed 50 per cent tariffs on Brazil and as the European Union braced for a possible letter from Trump with details on fresh tariffs.
"The increased rhetoric around tariffs, what we've seen this week regarding Brazil and Canada, is certainly elevating the anxiety level," Michael James, an equity sales trader at Rosenblatt Securities, said.
"People had become a little more accustomed to the lack of negative tariff headlines, and we've kind of been reminded that the tariff picture is still there."
Shares of Nvidia rose 0.5 per cent to a record high, lifting its stock market value to $US4.02 trillion ($A6.10 trillion).
Drone makers AeroVironment and Kratos Defense & Security Solutions jumped about 11 per cent after US Defense Secretary Pete Hegseth ordered a surge in drone production and deployment.
The S&P 500 declined 0.33 per cent to end the session at 6,259.75 points, the Nasdaq declined 0.22 per cent to 20,585.53 points and the Dow Jones Industrial Average fell 0.63 per cent to 44,371.51 points.
Volume on US exchanges was relatively light, with 15.4 billion shares traded, compared with an average of 18.3 billion shares over the previous 20 sessions.
For the week, the S&P 500 dipped 0.3 per cent, the Dow lost about 1.0 per cent and the Nasdaq slipped 0.1 per cent.
The S&P 500 is up about 6.0 per cent so far in 2025.
Investors will soon turn their attention to second-quarter reporting season, with a focus on how Trump's on-again off-again tariffs are affecting major US companies.
Among the big names reporting results next week are JPMorgan, Netflix and Johnson & Johnson.
Analysts on average expect S&P 500 companies to increase their second-quarter earnings by 5.7 per cent, year over year, with big gains from tech companies and declining profits in energy, consumer staples and consumer discretionary, according to LSEG I/B/E/S.
"We believe expectations are a bit low for S&P 500 earnings. Much of the second quarter was marked with tariff and trade issues and that may have caused some dislocations in earnings," said Michael Landsberg, chief investment officer, Landsberg Bennett Private Wealth Management.
Levi Strauss & Co jumped 11 per cent after the apparel seller raised its annual revenue and profit forecasts and beat quarterly estimates.
Meta Platforms shares closed 1.3 per cent lower after Reuters reported that the company is very unlikely to offer more changes to its pay-or-consent model, increasing the risk of fresh European Union antitrust charges and hefty daily fines.
Kraft Heinz closed 2.5 per cent higher after the Wall Street Journal reported the company is preparing to break itself up as the packaged food maker grapples with persistent weakness in demand for its higher-priced brands.
Across the US stock market, declining stocks outnumbered rising ones by a 2.8-to-one ratio.
The S&P 500 posted 12 new highs and 4 new lows; the Nasdaq recorded 58 new highs and 43 new lows.
Wall Street has ended lower, with Meta Platforms weighing on the S&P 500 after President Donald Trump intensified his tariff offensive against Canada, amplifying the uncertainty swirling around US trade policy.
Trump late on Thursday ramped up his tariff assault on Canada, saying the US would impose a 35 per cent tariff on imports next month and planned to impose blanket tariffs of 15 per cent or 20 per cent on most other trading partners.
The S&P 500 eased from a record high the day before, with caution prevailing after Trump on Thursday imposed 50 per cent tariffs on Brazil and as the European Union braced for a possible letter from Trump with details on fresh tariffs.
"The increased rhetoric around tariffs, what we've seen this week regarding Brazil and Canada, is certainly elevating the anxiety level," Michael James, an equity sales trader at Rosenblatt Securities, said.
"People had become a little more accustomed to the lack of negative tariff headlines, and we've kind of been reminded that the tariff picture is still there."
Shares of Nvidia rose 0.5 per cent to a record high, lifting its stock market value to $US4.02 trillion ($A6.10 trillion).
Drone makers AeroVironment and Kratos Defense & Security Solutions jumped about 11 per cent after US Defense Secretary Pete Hegseth ordered a surge in drone production and deployment.
The S&P 500 declined 0.33 per cent to end the session at 6,259.75 points, the Nasdaq declined 0.22 per cent to 20,585.53 points and the Dow Jones Industrial Average fell 0.63 per cent to 44,371.51 points.
Volume on US exchanges was relatively light, with 15.4 billion shares traded, compared with an average of 18.3 billion shares over the previous 20 sessions.
For the week, the S&P 500 dipped 0.3 per cent, the Dow lost about 1.0 per cent and the Nasdaq slipped 0.1 per cent.
The S&P 500 is up about 6.0 per cent so far in 2025.
Investors will soon turn their attention to second-quarter reporting season, with a focus on how Trump's on-again off-again tariffs are affecting major US companies.
Among the big names reporting results next week are JPMorgan, Netflix and Johnson & Johnson.
Analysts on average expect S&P 500 companies to increase their second-quarter earnings by 5.7 per cent, year over year, with big gains from tech companies and declining profits in energy, consumer staples and consumer discretionary, according to LSEG I/B/E/S.
"We believe expectations are a bit low for S&P 500 earnings. Much of the second quarter was marked with tariff and trade issues and that may have caused some dislocations in earnings," said Michael Landsberg, chief investment officer, Landsberg Bennett Private Wealth Management.
Levi Strauss & Co jumped 11 per cent after the apparel seller raised its annual revenue and profit forecasts and beat quarterly estimates.
Meta Platforms shares closed 1.3 per cent lower after Reuters reported that the company is very unlikely to offer more changes to its pay-or-consent model, increasing the risk of fresh European Union antitrust charges and hefty daily fines.
Kraft Heinz closed 2.5 per cent higher after the Wall Street Journal reported the company is preparing to break itself up as the packaged food maker grapples with persistent weakness in demand for its higher-priced brands.
Across the US stock market, declining stocks outnumbered rising ones by a 2.8-to-one ratio.
The S&P 500 posted 12 new highs and 4 new lows; the Nasdaq recorded 58 new highs and 43 new lows.
Wall Street has ended lower, with Meta Platforms weighing on the S&P 500 after President Donald Trump intensified his tariff offensive against Canada, amplifying the uncertainty swirling around US trade policy.
Trump late on Thursday ramped up his tariff assault on Canada, saying the US would impose a 35 per cent tariff on imports next month and planned to impose blanket tariffs of 15 per cent or 20 per cent on most other trading partners.
The S&P 500 eased from a record high the day before, with caution prevailing after Trump on Thursday imposed 50 per cent tariffs on Brazil and as the European Union braced for a possible letter from Trump with details on fresh tariffs.
"The increased rhetoric around tariffs, what we've seen this week regarding Brazil and Canada, is certainly elevating the anxiety level," Michael James, an equity sales trader at Rosenblatt Securities, said.
"People had become a little more accustomed to the lack of negative tariff headlines, and we've kind of been reminded that the tariff picture is still there."
Shares of Nvidia rose 0.5 per cent to a record high, lifting its stock market value to $US4.02 trillion ($A6.10 trillion).
Drone makers AeroVironment and Kratos Defense & Security Solutions jumped about 11 per cent after US Defense Secretary Pete Hegseth ordered a surge in drone production and deployment.
The S&P 500 declined 0.33 per cent to end the session at 6,259.75 points, the Nasdaq declined 0.22 per cent to 20,585.53 points and the Dow Jones Industrial Average fell 0.63 per cent to 44,371.51 points.
Volume on US exchanges was relatively light, with 15.4 billion shares traded, compared with an average of 18.3 billion shares over the previous 20 sessions.
For the week, the S&P 500 dipped 0.3 per cent, the Dow lost about 1.0 per cent and the Nasdaq slipped 0.1 per cent.
The S&P 500 is up about 6.0 per cent so far in 2025.
Investors will soon turn their attention to second-quarter reporting season, with a focus on how Trump's on-again off-again tariffs are affecting major US companies.
Among the big names reporting results next week are JPMorgan, Netflix and Johnson & Johnson.
Analysts on average expect S&P 500 companies to increase their second-quarter earnings by 5.7 per cent, year over year, with big gains from tech companies and declining profits in energy, consumer staples and consumer discretionary, according to LSEG I/B/E/S.
"We believe expectations are a bit low for S&P 500 earnings. Much of the second quarter was marked with tariff and trade issues and that may have caused some dislocations in earnings," said Michael Landsberg, chief investment officer, Landsberg Bennett Private Wealth Management.
Levi Strauss & Co jumped 11 per cent after the apparel seller raised its annual revenue and profit forecasts and beat quarterly estimates.
Meta Platforms shares closed 1.3 per cent lower after Reuters reported that the company is very unlikely to offer more changes to its pay-or-consent model, increasing the risk of fresh European Union antitrust charges and hefty daily fines.
Kraft Heinz closed 2.5 per cent higher after the Wall Street Journal reported the company is preparing to break itself up as the packaged food maker grapples with persistent weakness in demand for its higher-priced brands.
Across the US stock market, declining stocks outnumbered rising ones by a 2.8-to-one ratio.
The S&P 500 posted 12 new highs and 4 new lows; the Nasdaq recorded 58 new highs and 43 new lows.
Wall Street has ended lower, with Meta Platforms weighing on the S&P 500 after President Donald Trump intensified his tariff offensive against Canada, amplifying the uncertainty swirling around US trade policy.
Trump late on Thursday ramped up his tariff assault on Canada, saying the US would impose a 35 per cent tariff on imports next month and planned to impose blanket tariffs of 15 per cent or 20 per cent on most other trading partners.
The S&P 500 eased from a record high the day before, with caution prevailing after Trump on Thursday imposed 50 per cent tariffs on Brazil and as the European Union braced for a possible letter from Trump with details on fresh tariffs.
"The increased rhetoric around tariffs, what we've seen this week regarding Brazil and Canada, is certainly elevating the anxiety level," Michael James, an equity sales trader at Rosenblatt Securities, said.
"People had become a little more accustomed to the lack of negative tariff headlines, and we've kind of been reminded that the tariff picture is still there."
Shares of Nvidia rose 0.5 per cent to a record high, lifting its stock market value to $US4.02 trillion ($A6.10 trillion).
Drone makers AeroVironment and Kratos Defense & Security Solutions jumped about 11 per cent after US Defense Secretary Pete Hegseth ordered a surge in drone production and deployment.
The S&P 500 declined 0.33 per cent to end the session at 6,259.75 points, the Nasdaq declined 0.22 per cent to 20,585.53 points and the Dow Jones Industrial Average fell 0.63 per cent to 44,371.51 points.
Volume on US exchanges was relatively light, with 15.4 billion shares traded, compared with an average of 18.3 billion shares over the previous 20 sessions.
For the week, the S&P 500 dipped 0.3 per cent, the Dow lost about 1.0 per cent and the Nasdaq slipped 0.1 per cent.
The S&P 500 is up about 6.0 per cent so far in 2025.
Investors will soon turn their attention to second-quarter reporting season, with a focus on how Trump's on-again off-again tariffs are affecting major US companies.
Among the big names reporting results next week are JPMorgan, Netflix and Johnson & Johnson.
Analysts on average expect S&P 500 companies to increase their second-quarter earnings by 5.7 per cent, year over year, with big gains from tech companies and declining profits in energy, consumer staples and consumer discretionary, according to LSEG I/B/E/S.
"We believe expectations are a bit low for S&P 500 earnings. Much of the second quarter was marked with tariff and trade issues and that may have caused some dislocations in earnings," said Michael Landsberg, chief investment officer, Landsberg Bennett Private Wealth Management.
Levi Strauss & Co jumped 11 per cent after the apparel seller raised its annual revenue and profit forecasts and beat quarterly estimates.
Meta Platforms shares closed 1.3 per cent lower after Reuters reported that the company is very unlikely to offer more changes to its pay-or-consent model, increasing the risk of fresh European Union antitrust charges and hefty daily fines.
Kraft Heinz closed 2.5 per cent higher after the Wall Street Journal reported the company is preparing to break itself up as the packaged food maker grapples with persistent weakness in demand for its higher-priced brands.
Across the US stock market, declining stocks outnumbered rising ones by a 2.8-to-one ratio.
The S&P 500 posted 12 new highs and 4 new lows; the Nasdaq recorded 58 new highs and 43 new lows.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News AU
38 minutes ago
- Sky News AU
Rosie O'Donnell tears into Donald Trump claiming he's on the Epstein client list after he threatened to revoke her citizenship
Rosie O'Donnell has gone on a scathing attack against US President Donald Trump after he threatened to revoke her American citizenship. The former host of The View posted a series of posts on Saturday claiming Trump was on Jeffrey Epstein's client list and was a guest at the sex trafficker's island after the president hit out at the comedian expatriate. 'Because of the fact that Rosie O'Donnell is not in the best interests of our Great Country, I am giving serious consideration to taking away her Citizenship,' Mr Trump wrote via Truth Social on Saturday. 'She is a Threat to Humanity, and should remain in the wonderful Country of Ireland, if they want her. GOD BLESS AMERICA.' O'Donnell went on a social media blitz of posts and fired back in a lengthy response towards the US President. 'The president of the USA has always hated the fact that I see him for who he is - a criminal con man sexual abusing liar out to harm our nation to serve himself - this is why I moved to Ireland - he is a dangerous old soulless man with dementia who lacks empathy compassion and basic humanity,' O'Donnell said. She wrote that she stands 'in direct opposition all he represents,' noting that 'so do millions of others' and asked 'u gonna deport all who stand against ur evil tendencies". The 63-year-old concluded the post by calling Trump a 'bad joke who can't form a coherent sentence' and added the hashtag "#nevertrump". In a flurry of posts the former TV host hit back again and asked Trump if he was rattled again. 'Hey Donald – you're rattled again? 18 years later and I still live rent-free in that collapsing brain of yours,' O'Donnell said. 'You call me a threat to humanity – but I'm everything you fear: a loud woman, a queer woman, a mother who tells the truth, an American who got out of the country b4 u set it ablaze. 'You build walls –I build a life for my autistic kid in a country where decency still exists. 'You crave loyalty –I teach my children to question power. 'You sell fear on golf courses –I make art about surviving trauma. 'You lie, you steal, you degrade –I nurture, I create, I persist.' O'Donnell added Trump is 'everything that is wrong America' and she was everything he hated about what was still good about the United States. 'You want to revoke my citizenship? go ahead and try, king joffrey with a tangerine spray tan. 'I'm not yours to silence I never was.' The actress announced in March, she moved to Ireland following Trump's second term in office in November. The re-ignited feud between Trump and O'Donnell comes after US Attorney General Pam Bondi is facing heavy scrutiny after the Department of Justice revealed there is no Jeffrey Epstein client list. 'She is stuttering and spluttering all over her words, and it's not really clear what she is trying to accomplish,' UnHerd newsroom editor James Billot told Sky News Digital Presenter Gabriella Power. 'I completely understand why the MAGA base is in uproar about this.'
9 News
an hour ago
- 9 News
California farmworker who fell from roof during chaotic ICE raid dies
Your web browser is no longer supported. To improve your experience update it here A farmworker who fell from a greenhouse roof during a chaotic ICE raid this week at a California cannabis facility died on Saturday of his injuries. Jaime Alanis, 57, is the first person to die in one of the Trump administration's anti-immigration operations. Yesenia Duran, Alanis' niece, confirmed his death to The Associated Press. Duran has posted on the fundraising site GoFundMe to say her uncle was his family's only provider and he had been sending his earnings back to a wife and daughter in Mexico. Jaime Alanis, 57, is the first person to die in one of the Trump administration's anti-immigration operations. (Supplied) The United Food Workers said Alanis worked at the farm for 10 years. 'These violent and cruel federal actions terrorize American communities, disrupt the American food supply chain, threaten lives and separate families,' the union said recently in a statement on the social platform X. The UFW reported Alanis' death prematurely late on Friday, but the Ventura County Medical Center later issued a statement authorised by the family saying he was still on life support. The Department of Homeland Security said it executed criminal search warrants Thursday at Glass House Farms facilities in Camarillo and Carpinteria. Garcia called family to say he was hiding and possibly was fleeing agents before he fell about nine meters from the roof and broke his neck, according to information from family, hospital and government sources. Agents arrested some 200 people suspected of being in the country illegally and identified at least 10 immigrant children on the sites, DHS said in a statement. Garcia called family to say he was hiding and possibly was fleeing agents before he fell about nine meters from the roof and broke his neck, according to information from family, hospital and government sources. (Supplied) Alanis was not among them, the agency said. 'This man was not in and has not been in CBP or ICE custody,' DHS Assistant Secretary for Public Affairs Tricia McLaughlin said in a statement. 'Although he was not being pursued by law enforcement, this individual climbed up to the roof of a greenhouse and fell 30 feet. CBP immediately called a medivac to the scene to get him care as quickly as possible.' Four US citizens were arrested during the incident for allegedly 'assaulting or resisting officers,' according to DHS, and authorities were offering a $76,000 (US$50,000) reward for information leading to the arrest of a person suspected of firing a gun at federal agents. During the raid crowds of people gathered outside the facility in Camarillo to seek information about their relatives and protest immigration enforcement. Authorities clad in military-style helmets and uniforms faced off with the demonstrators, and people ultimately retreated amid acrid green and white billowing smoke. Glass House, a licensed California cannabis grower, said in a statement that immigration agents had valid warrants. The company said workers were detained and it is helping provide them with legal representation. The farm also grows tomatoes and cucumbers. 'Glass House has never knowingly violated applicable hiring practices and does not and has never employed minors,' it said. The business is owned by Graham Farrar, a generous donor to California Democrats including Gov. Gavin Newsom, a vocal critic of Republican President Donald Trump. USA immigration World Donald Trump CONTACT US
7NEWS
an hour ago
- 7NEWS
Trump has flagged 200 per cent tariffs on Australian pharmaceuticals. What do we produce here, and what's at risk?
This article first appeared in The Conversation. US President Donald Trump's proposed tariffs on Australia's pharmaceutical exports to the United States has raised alarm among industry and government leaders. There are fears that, if implemented, the tariffs could cost the Australian economy up to A$2.8 billion. That's both in direct exports and as inputs to third countries that produce drugs also hit by tariffs. The proposed tariffs come amid growing pressure from pharmaceutical lobby groups in the US for Trump to use trade negotiations as a tool to make changes to the Pharmaceutical Benefits Scheme (PBS) and raise Australian drug prices. In response, Treasurer Jim Chalmers stated the government would not compromise the integrity of the PBS to do a deal with the Trump administration. Nationals Senator Bridget McKenzie also confirmed bipartisan support for the PBS. Our largest export market for pharmaceuticals The US is Australia's biggest pharmaceutical export market, accounting for 38 per cent of total Australian pharmaceutical exports and valued at $2.2 billion last year. About 87 per cent of exports to the US consist of blood plasma products, mainly from manufacturing giant CSL. These are used for transfusions in a range of medical and surgical situations. In a submission to the US Commerce Department, which is reviewing the sector, CSL called for tariffs to be phased in over five years, and for an exemption for certain biotech equipment. Trump floated proposed tariffs potentially as high as 200 per cent. But he also said these would not be imposed for 'about a year, a year and a half' to allow negotiations to take place. If tariffs are eventually implemented, there are fears domestic manufacturing may suffer, with negative flow-on effects for Australian research and innovation in the sector. How does the PBS work? The PBS is an Australian government program aimed at providing affordable prescription medicines to Australians. It helps reduce the cost of essential medications, ensuring access to treatments for a wide range of medical conditions. Medicines included on the PBS are subsidised by the government, with the patient making a capped co-payment. More than 900 medicines were listed on the scheme in 2023–24, costing the government $17.7 billion. Decisions to list medications on the PBS are made by the health minister based on recommendations from the Pharmaceutical Benefits Advisory Committee. The committee evaluates the clinical effectiveness, safety, cost-effectiveness ('value for money') and estimated financial impact of new medications. If approved, the PBS uses this information to negotiate directly with pharmaceutical companies, helping to keep prices affordable. How does the US system compare? This contrasts with the US system, which operates more under free-market principles. In the US, pharmaceuticals are subsidised through private health insurance or government programs such as Medicaid. Neither directly negotiates with pharmaceutical companies. The fragmented nature of the US system enables pharmaceutical companies to maintain higher prices, as there is no central authority to enforce cost controls. Studies have shown that prices for pharmaceuticals in the US are, on average, 2.78 times those in 33 other countries. In addition, in the US pharmaceutical companies are granted extensive patent protections. These provide exclusive rights to sell their drugs for a certain period. This exclusivity often leads to monopolistic pricing practices, as generic competitors are barred from entering the market until the patent expires. In Australia, patents also exist. But the PBS mitigates their impact by negotiating prices and promoting the use of cost-effective alternatives, such as generics, once they become available. Industry lobbying US pharmaceutical industry bodies have long criticised the PBS. They claim the scheme 'undervalues new innovative medicines by setting prices based on older inferior medicines and generics, and through use of low and outdated monetary thresholds per year of life gained from clinically proven treatments'. The slow process to list drugs on the PBS has also attracted criticism. The advisory committee meets only three times a year, with resources currently being stretched beyond capacity. In response to these criticisms, the Australian government commissioned a review, which was completed in 2024. It provided 50 recommendations to ensure Australians can continue to access effective, safe and affordable medicines in an equitable and timely way. The government has established an advisory group to work on implementing these recommendations. However, it is unclear whether proposed changes will appease the powerful US pharmaceutical industry.
